Aspirin Could Cut Cancer Risk

Aspirin, a common drug, may significantly reduce cancer mortality when taken daily in low doses. Research suggests starting aspirin in the mid-40s and continuing until age 70 to maximize benefits while minimizing bleeding risks. Studies show aspirin reduces deaths from prostate, lung, bowel, and gullet cancers. Despite its low dose, aspirin can cause stomach bleeding, so it's recommended to take it with food or milk. Public perception is positive, given aspirin's historical use for heart disease and strokes. Ongoing research aims to confirm its long-term safety and effectiveness in cancer prevention.

What are the potential risks associated with taking aspirin?

What is the historical significance of aspirin as mentioned in the text?